Press Releases April 2, 2026 08:00 PM

First Hawaiian to Report First Quarter 2026 Financial Results on April 24, 2026

First Hawaiian, Inc. announces Q1 2026 earnings release and conference call scheduled for April 24, 2026.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
FHB

First Hawaiian, Inc., Hawaii's oldest and largest bank holding company, will release its first quarter 2026 financial results on April 24, 2026, before the U.S. market opens. The company will host a conference call the same day to discuss results, accessible via phone and webcast. First Hawaiian operates banking services across Hawaii, Guam, and Saipan, offering a broad range of consumer and commercial financial products.

First Hawaiian to Report First Quarter 2026 Financial Results on April 24, 2026
FHB
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Scheduled Q1 2026 earnings release on April 24, with an accompanying conference call.
  • First Hawaiian is Hawaii’s oldest and largest financial institution, serving Hawaii, Guam, and Saipan.
  • The company offers diverse banking, wealth management, and financial services to consumers and businesses.
  • Impacted sectors: Financial services, banking, regional economic markets for Hawaii and nearby territories.

HONOLULU, April 03, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its first quarter 2026 financial results on Friday, April 24, 2026 before the market opens. First Hawaiian will host a conference call to discuss the company’s results on the same day at 1:00 p.m. Eastern Time (7:00 a.m. Hawaii Time).

To access the call by phone, participants will need to click on the following registration link: https://register-conf.media-server.com/register/BI91896a5e1d8b487a89f5948ca1270853, register for the conference call, and then you will receive the dial-in number and a personalized PIN code. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time.

A live webcast of the conference call, including a slide presentation, will be available at the following link: www.fhb.com/earnings. The archive of the webcast will be available at the same location.

About First Hawaiian

First Hawaiian, Inc. (NASDAQ:FHB) is a bank holding company headquartered in Honolulu, Hawaii. Its principal subsidiary, First Hawaiian Bank, founded in 1858 under the name Bishop & Company, is Hawaii’s oldest and largest financial institution with branch locations throughout Hawaii, Guam and Saipan. The company offers a comprehensive suite of banking services to consumer and commercial customers including deposit products, loans, wealth management, insurance, trust, retirement planning, credit card and merchant processing services. Customers may also access their accounts through ATMs, online and mobile banking channels. For more information about First Hawaiian, Inc., visit www.FHB.com.

Investor Relations Contact:
Kevin Haseyama
(808) 525-6268
[email protected]

Media Contact:
Lindsay Chambers
(808) 525-6254
[email protected]


Risks

  • Financial results may be affected by regional economic conditions in Hawaii and Pacific territories, impacting loan performance and deposit growth.
  • Potential variability in interest rates could influence net interest margins and profitability.
  • Uncertain macroeconomic factors and competitive pressures in the banking sector could affect future earnings and growth prospects.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026